Stifel Maintains Disc Medicine(IRON.US) With Buy Rating, Raises Target Price to $79

Stifel analyst Benjamin Burnett maintains $Disc Medicine(IRON.US)$ with a buy rating, and adjusts the target price from $72 to $79.According to TipRanks data, the analyst has a success rate of 35.3% a

moomoo NewsJun 17 22:32 ET · Ratings

BMO Capital Maintains Disc Medicine(IRON.US) With Buy Rating, Cuts Target Price to $50

BMO Capital analyst Evan Seigerman maintains $Disc Medicine(IRON.US)$ with a buy rating, and adjusts the target price from $70 to $50.According to TipRanks data, the analyst has a success rate of 0.0%

moomoo NewsJun 17 14:31 ET · Ratings

BMO Capital Reiterates Outperform on Disc Medicine, Raises Price Target to $70

BMO Capital analyst Evan Seigerman reiterates Disc Medicine (NASDAQ:IRON) with a Outperform and raises the price target from $50 to $70.

BenzingaJun 17 09:15 ET

Express News | Disc Medicine Inc : Wedbush Raises Target Price to $57 From $43

ReutersJun 17 00:55 ET

A Quick Look at Today's Ratings for Disc Medicine(IRON.US), With a Forecast Between $57 to $70

On Jun 15, major Wall Street analysts update their ratings for $Disc Medicine(IRON.US)$, with price targets ranging from $57 to $70.BMO Capital analyst Evan Seigerman maintains with a buy rating, and

moomoo NewsJun 15 09:00 ET · Ratings

S&P 500 Edges Lower; RH Shares Plunge After Q1 Results

U.S. stocks traded mixed toward the trading, with the Dow Jones index falling around 0.2% on Friday.The Dow traded down 0.24% to 38,554.69 while the NASDAQ rose 0.07% to 17,680.01. The S&P 500 also fe

BenzingaJun 14 15:36 ET